Approaches to analyzing efficiency of respiratory protective equipment as a way to reduce health risks during COVID-19 pandemic

View or download the full article: 
UDC: 
614.446.1:578.834.1
Authors: 

E.A. Shashina1, T.S. Isiutina-Fedotkova1, V.V. Makarova1, O.A. Gruzdeva2, O.V. Mitrokhin1

Organization: 

1 I.M. Sechenov First Moscow State Medical University, Bldg. 2, 8 Trubetskaya Str., Moscow, 119991, Russian Federation
2 Center for Hygiene and Epidemiology in Moscow, the Central Administrative District brunch, Bldg. 1, 17 Krasnogvardeiskii blvd., Moscow, 123317, Russian Federation

Abstract: 

Use of respiratory protective equipment (RPE) has become the most significant way to prevent the coronavirus infection from its rapid spread.
Our research goal was to analyze efficiency of various RPE used by people during COVID-19 pandemic.
We made a review focusing on RPE manufactured and tested as per standards existing in different counties; we also analyzed the State Medical Equipment Register of the Federal Service for Surveillance in Public Healthcare as well as a market where respiratory protective equipment available to people was distributed.
RPE is quite variable as per such parameters as bacterial filtration efficiency, number of layers and quality of a material it is made of, being fit to a person’s face (masks for children/adults), conditions for use (a time of use, whether a mask can be disinfected and used again, etc.). Data provided for customers when respiratory protective equipment is sold are rather scarce and controversial (people do not understand what a mask name means and how efficiently it protects their respiratory organs). Respiratory protective equipment which is registered within the State Medical Equipment Register of the Federal Service for Surveillance in Public Healthcare accounts for only 24% of the overall equipment sold to consumers. Taking into account variable and multiple properties of different masks, we developed a RPE classification basing on their efficiency when it comes down to protection from respiratory infections. FFP3/KN100/N99/N100 respirators are the most efficient ones. FFP2/KN95/N95/DS/DL2/KF94 respirators have average efficiency. FFP1 respirators and nonwoven medicals masks, II R, II, I type, and woven gauze masks have efficiency that is lower than average (RPE is mentioned in a descending order as per its efficiency). Low and extremely low efficiency was established accordingly for various non-medical masks (nonwoven, woven cotton, and synthetic ones) and face shields.
When RPE is manufactured and sold, there are no precise criteria for assessing its protective efficiency. There is either no unified approach to such concepts as «medical» and «non-medical» masks. Most respiratory protective equipment sold on the consumer market in Russia is not registered within the Russian State Medical Equipment Register of the Federal Service for Surveillance in Public Healthcare. Our classification allows working out a unified approach to providing data on respiratory protective equipment for consumers.

Keywords: 
pandemic, COVID-19, respiratory protective equipment, medical mask, non-medical mask, bacterial filtration efficiency, the State Medical Equipment Register, protective equipment market
Shashina E.A., Isiutina-Fedotkova T.S., Makarova V.V., Gruzdeva O.A., Mitrokhin O.V. Approaches to analyzing efficiency of respiratory protective equipment as a way to reduce health risks during COVID-19 pandemic. Health Risk Analysis, 2021, no. 1, pp. 151–158. DOI: 10.21668/health.risk/2021.1.16.eng
References: 
  1. COVID-19: One year later – WHO Director-General’s New Year message. World health organization, 2020. Available at: https://www.who.int/ru/news/item/30-12-2020-covid-19-anniversary-and-loo... (10.02.2021).
  2. WHO Coronavirus Disease (COVID-19) Dashboard. World health organization, 2020. Available at: https://covid19.who.int/ (10.02.2021).
  3. Coronavirus disease (COVID-19): Herd immunity, lockdowns and COVID-19. World health organization, 2020. Available at: https://www.who.int/ru/news-room/q-a-detail/herd-immunity-lockdowns-and-... (10.02.2021).
  4. Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief, 09 July 2020. World health organization, 2020. Available at: https://apps.who.int/iris/handle/10665/333114 (10.02.2021).
  5. Zhang R., Li Y., Zhang A.L., Wang Y., Molina M.J. Identifying airborne transmission as the dominant route for the spread of COVID-19. Proceedings of the National Academy of Sciences, 2020, vol. 117, no. 26, pp. 14857–14863. DOI: 10.1073/pnas.2009637117
  6. Chu D.K., Akl E.A., Duda S., Yaacoub S., Solo K., Schünemann H.J. Physical distancing, face masks and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet, 2020, vol. 395, no. 10242, pp. 1973–1987. DOI: 10.1016/S0140-6736(20)31142-9
  7. Chiu N.-C., Chi H., Tai Y.-L., Peng C.-C., Tseng C.-Y., Chen C.-C., Tan B.F., Lin C.-Y. Impact of wearing masks, hand hygiene, and social distancing on influenza, enterovirus, and all-cause pneumonia during the coronavirus pandemic: Retrospective national epidemiological surveillance study. J. Med. Internet Res, 2020, no. 22, pp. e21257. DOI: 10.2196/21257
  8. Abboah-Offei M., Salifu Y., Adewale B., Bayuo J., Ofosu-Poku R., Opare-Lokko E.B.A. A rapid review of the use of face mask in preventing the spread of COVID-19. Int J Nurs Stud Adv, 2021, no. 3, pp. 100013. DOI: 10.1016/j.ijnsa.2020.100013
  9. Clapp P.W., Sickbert-Bennett E.E., Samet J.M., Berntsen J., Zeman K.L., Anderson D.J., Weber D.J., Bennett W.D. Evaluation of cloth masks and modified procedure masks as personal protective equipment for the public during the COVID-19 pandemic. JAMA Internal Medicine, 2020, no. 10, pp. e208168. DOI: 10.1001/jamainternmed.2020.8168
  10. Primenenie masok v usloviyakh COVID-19. Vremennye rekomendatsii 1 dekabrya 2020 g. [Mask use in the context of COVID-19. Interim guidance. December 1, 2020]. World health organization, 2020, 28 p. (in Russian).
  11. Eikenberry S.E., Mancuso M., Iboi E., Phan T., Eikenberry K., Kuang Y., Kostelich E., Gumel A.B. To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Infect Dis Model, 2020, no. 5, pp. 293–308. DOI: 10.1016/j.idm.2020.04.001
  12. Ngonghala C.N., Iboi E., Eikenberry S., Scotch M., MacIntyre C.R., Bonds M.H., Gumel A.B. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus. Math Biosci, 2020, no. 325, pp. 108364. DOI: 10.1016/j.mbs.2020.108364
  13. Stutt R., Retkute R., Bradley M., Gilligan C.A., Colvin J. A modelling framework to assess the likely effectiveness of facemasks in combination with «lock-down» in managing the COVID-19 pandemic. Proc R Soc A Math Phys Eng Sci, 2020, vol. 476, no. 2238, pp. 0376. DOI: 10.1098/rspa.2020.0376
  14. Worby C.J., Chang H.H. Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic. Nat Commun, 2020, vol. 1, no. 1, pp. 4049. DOI: 10.1038/s41467-020-17922-x
  15. Liao L., Xiao W., Zhao M., Yu X., Wang H., Wang Q., Chu S., Cui Y. Can N95 Respirators Be Reused after Disinfection? How Many Times? ACS Nano, 2020, no. 14, pp. 6348−6356. DOI: 10.1021/acsnano.0c03597
  16. Primenenie masok v kontekste COVID-19. Vremennye rekomendatsii 5 iyunya 2020 g. [Mask use in the context of COVID-19. Interim guidance. June 5, 2020]. World health organization, 2020, 20 p. (in Russian).
  17. CDC Use Masks to Slow the Spread of COVID-19. Centers for Disease Control and Prevention, 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/diy-cloth... (10.02.2021).
  18. Kumar S. The perspective of fluid flow behavior of respiratory droplets and aerosols through the facemasks in context of SARS-CoV-2. Phys Fluids, 2020, vol. 32, no. 11, pp. 111301–111315. DOI: 10.1063/5.0029767–15
  19. Perencevich E.N., Diekema D.J., Edmond M.B. Moving personal protective equipment into the community: Face shields and containment of COVID-19. Jama, 2020, no. 323, pp. 2252. DOI: 10.1001/jama.2020.7477
Received: 
25.02.2021
Accepted: 
03.03.2021
Published: 
30.03.2021

You are here